> For the complete documentation index, see [llms.txt](https://www.brexatlas.org/llms.txt). Markdown versions of documentation pages are available by appending `.md` to page URLs; this page is available as [Markdown](https://www.brexatlas.org/bre-001/bre-011.md). # BRE 011 **Supportive Oncology, Digital Meditation, and Treatment Adoption** **Clinical Focus:** Multiple Cancer Types\ **Common Focus:** How Cancer Patients Respond to Supportive Care Tools ## Source Godinho, A., et al. (2025). *Listening in: Identifying Considerations for Integrating Complementary Therapy into Oncology Care Across Patient, Clinic, and System Levels—A Case Example of a Digital Meditation Tool.* *Current Oncology.* *** ## BRS Score **BRS:** 6.6 / 10\ **STEMD:** S6 / T9 / E7 / M4 / D7\ **External Evidence Level:** Moderate for patient adoption and implementation evidence; Very Low for direct bioelectric or cancer-response evidence ## Score Interpretation BRE-011 receives a moderate BRS because it provides real patient-facing implementation evidence, but it does not test electric fields, frequency exposure, cancer-cell response, tumor progression, or biological mechanisms. Its strongest value is translation. This entry helps BREXAtlas think about how future bioelectric or supportive technologies may actually move into patient care. *** ## Entry Summary BRE-011 asks a practical question: Even if a new cancer-support tool exists, will patients actually use it? This study examined interest in a digital meditation tool among cancer patients. It was not a bioelectric treatment study. It did not measure tumor response. It did not test frequencies. Instead, it studied patient interest, adoption barriers, and supportive-care integration. That matters because future bioelectric oncology will not only depend on scientific discovery. It will also depend on whether patients, clinics, and health systems can understand, trust, access, and use new interventions. *** ## Question This BRE Helps Answer Why does patient adoption matter for BREXAtlas? What BREXAtlas found: Future bioelectric tools may fail if they are scientifically interesting but difficult to adopt. BRE-011 shows that patient interest is shaped by: * prior experience * stress coping needs * age * sex * knowledge gaps * clinic integration * system-level support This is important because future BREXAtlas outputs may include wearable devices, digital platforms, clinical decision tools, educational systems, or supportive oncology technologies. *** ## What did the study find? The study included 148 cancer patients across several cancer categories. Key findings included: | Finding | Result | | ------------------------------------- | --------- | | Interested in digital meditation tool | 42% | | Never previously meditated | 65% | | Average time since diagnosis | 26 months | The study also found that stress coping predicted interest, female patients showed greater interest, and older age reduced interest. *** ## Cancer Types Included BRE-011 included patients with: * gastrointestinal cancer * breast cancer * blood cancer * respiratory cancer * genitourinary cancer *** ## Intervention Studied | Category | Classification | | ---------------------------------- | ------------------------------------------------------- | | Intervention | Digital Meditation Tool | | Framework | Behavioural Design Space | | Study Type | Cross-sectional survey / implementation framework study | | Sample Size | 148 participants | | Direct Frequency Exposure | No | | Direct Bioelectromagnetic Exposure | No | | Direct Cancer-Response Outcome | No | *** ## What BREXAtlas Found BREXAtlas classifies BRE-011 as a supportive-care and implementation entry. Its contribution is not biological proof. Its contribution is translation insight. It helps answer: * Who is likely to adopt supportive tools? * What barriers prevent use? * How do patients evaluate nontraditional interventions? * How should future patient-facing systems be designed? * What makes an intervention usable in oncology care? *** ## Mechanisms ### MEC-037: Stress Reduction Pathway The study indirectly supports a pathway in which stress reduction may improve coping. Stress reduction\ ↓\ Improved coping\ ↓\ Potential quality-of-life improvement This is not a tumor-response mechanism. It is a supportive-care mechanism. ### MEC-038: Patient Adoption Behavior Patient adoption is influenced by perceived need, prior experience, demographic factors, and understanding of the intervention. ### MEC-039: Knowledge Gap Barrier Knowledge gaps may reduce uptake of supportive care tools. If patients do not understand the purpose of an intervention, they may not use it even when it is available. *** ## Public Source Validation Public oncology practice increasingly recognizes supportive care, distress management, and patient-centered implementation as important parts of cancer care. BRE-011 fits that public direction. BREXAtlas does not classify this paper as bioelectric treatment evidence. Instead, it uses the study to understand adoption, implementation, and patient-facing design. *** ## Connections to Other BRE Entries ### Connected to BRE-005 BRE-005 explored immune-related treatment enhancement. BRE-011 is not biologically connected to immunogenic cell death, but it is translationally connected. If future therapies involve combination care or patient-managed tools, adoption barriers will matter. ### Connected to BRE-006 BRE-006 emphasized systems thinking. BRE-011 applies systems thinking to oncology care delivery by examining patient, clinic, and system-level considerations. ### Connected to BRE-007 BRE-007 described cancer bioelectricity as an emerging field requiring translation pathways. BRE-011 provides an example of how supportive interventions may face adoption challenges in real oncology settings. ### Connected to Future Patient-Facing BREXAtlas Tools BRE-011 should inform future AskAtlasX and BREXAtlas website design. If patients and families use BREXAtlas to understand cancer-related technologies, the system must explain complex science clearly, reduce confusion, and avoid overclaiming. *** ## Research Gaps Identified * **RG-051: Biological Outcome Gap**\ No biological outcomes were measured. * **RG-052: Cancer Progression Gap**\ No cancer progression outcomes were evaluated. * **RG-053: Biomarker Gap**\ No physiological biomarkers were measured. * **RG-054: Adoption Equity Gap**\ More research is needed to understand how age, access, health literacy, and digital comfort affect adoption. * **RG-055: Supportive Tool Integration Gap**\ More research is needed on how digital supportive tools should be integrated into oncology clinics. *** ## Why This Entry Matters For researchers, BRE-011 explains that future interventions must be more than biologically promising. They must be usable. For patients and families, the key message is simple: Supportive care tools can help some people cope with cancer, but adoption depends on trust, clarity, access, and personal need. For BREXAtlas, the lesson is larger: A discovery is not fully useful until people can understand it, access it, and use it safely. *** ## Entry Conclusion BRE-011 is an implementation and supportive-care entry. It does not test bioelectric therapy. It does not validate frequencies. It does not measure tumor response. Its value is that it helps BREXAtlas prepare for real-world translation. The central question emerging from this entry is: How can future oncology tools be designed so patients understand them, trust them, and actually use them? For BREXAtlas, that question matters because scientific infrastructure must eventually become human-facing infrastructure. --- # Agent Instructions This documentation is published with GitBook. GitBook is the documentation platform designed so that both humans and AI agents can read, navigate, and reason over technical content effectively. Learn more at gitbook.com. ## Querying This Documentation If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question. Perform an HTTP GET request on the current page URL with the `ask` query parameter, and the optional `goal` query parameter: ``` GET https://www.brexatlas.org/bre-001/bre-011.md?ask=&goal= ``` `ask` is the immediate question: it should be specific, self-contained, and written in natural language. `goal` is optional and describes the broader end goal you are ultimately trying to accomplish on behalf of the user. GitBook uses it to tailor the answer towards what is most useful for that goal. The response will contain a direct answer to the question and relevant excerpts and sources from the documentation. Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.